Stay updated on Pembrolizumab Combo With Local Ablation in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Results posted with expanded outcome measures (ORR, TTR, Recurrence Free Survival, OS) and biomarker analyses, plus related study documents.
    Difference
    2%
    Check dated 2026-03-26T11:30:48.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    MeSH terms now include Hepatocellular carcinoma (HCC) and a link to the Genetic and Rare Diseases Information Center; the page footer shows Revision: v3.5.0, replacing v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-19T05:00:35.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T01:02:38.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the previous Revision: v3.4.1 notice, along with removing the funding status operating notice.
    Difference
    0.4%
    Check dated 2026-02-11T14:22:51.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the page version updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:31:01.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    A glossary is now displayed, and the QC update label has been capitalized from 'Last Update Submitted that met QC Criteria' to 'Last Update Submitted that Met QC Criteria'. The No FEAR Act Data label appears with updated capitalization, replacing the previous 'No FEAR Act data', and the revision reference updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:24:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo With Local Ablation in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.